Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/secukinumab-therapy-for-netherton-syndrome-hy300V5C00
References (19)
-
A. Palma, Juliette Mazereeuw-Hautier, K. Giehl, Á. Hernández-Martín, M. Merlos, P. Moons, Marie Morren, Marie Morren (2019)
Burden of itch in ichthyosis: a multicentre study in 94 patientsJournal of the European Academy of Dermatology and Venereology, 33
-
F. Tamarozzi, H. Wright, Huw Thomas, S. Edwards, M. Taylor (2014)
A lack of confirmation with alternative assays questions the validity of IL-17A expression in human neutrophils using immunohistochemistry.Immunology letters, 162 2 Pt B
-
S. Elman, L. Hynan, V. Gabriel, M. Mayo (2010)
The 5‐D itch scale: a new measure of pruritusBritish Journal of Dermatology, 162
-
De Palma (2019)
2095J Eur Acad Dermatol Venereol, 33
-
Â. Roda, M. Mendonça-Sanches, A. Travassos, L. Soares-de-Almeida, D. Metze (2017)
Infliximab therapy for Netherton syndrome: A case reportJAAD Case Reports, 3
-
L. Fontao, E. Laffitte, A. Briot, G. Kaya, P. Roux‐Lombard, S. Fraitag, A. Hovnanian, J. Saurat (2011)
Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin.The Journal of investigative dermatology, 131 9
-
T. Czarnowicki, H. He, A. Leonard, K. Malik, Shai Magidi, S. Rangel, K. Patel, K. Ramsey, M. Murphrey, T. Song, Y. Estrada, H. Wen, J. Krueger, E. Guttman‐Yassky, A. Paller (2018)
The Major Orphan Forms of Ichthyosis Are Characterized by Systemic T-Cell Activation and Th-17/Tc-17/Th-22/Tc-22 Polarization in Blood.The Journal of investigative dermatology, 138 10
-
J. Versteegh, K. Dulfer, Kira Stuvel, S. Pasmans, E. Utens (2018)
Netherton syndrome; neuropsychological and psychosocial functioning of child and adult patients and their parentsJournal of Health Psychology, 25
-
R. Langley, B. Elewski, M. Lebwohl, K. Reich, C. Griffiths, K. Papp, L. Puig, H. Nakagawa, L. Spelman, B. Sigurgeirsson, E. Rivas, T. Tsai, N. Wasel, S. Tyring, T. Salko, I. Hampele, M. Notter, A. Karpov, S. Helou, C. Papavassilis (2014)
Secukinumab in plaque psoriasis--results of two phase 3 trials.The New England journal of medicine, 371 4
-
W. Hartschuh, I. Hausser, D. Petzoldt (1989)
[Successful retinoid therapy of Netherton syndrome].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 40 7
-
A. Paller, Y. Renert-Yuval, M. Suprun, H. Esaki, M. Oliva, T. Huynh, B. Ungar, Norma Kunjravia, R. Friedland, Xiangyu Peng, Xiuzhong Zheng, Y. Estrada, J. Krueger, K. Choate, M. Suárez-Fariñas, E. Guttman‐Yassky (2017)
An IL‐17–dominant immune profile is shared across the major orphan forms of ichthyosisThe Journal of Allergy and Clinical Immunology, 139
-
L. Furio, A. Hovnanian (2014)
Netherton syndrome: defective kallikrein inhibition in the skin leads to skin inflammation and allergyBiological Chemistry, 395
-
W Hartschuh, I Hausser, D Petzoldt (1989)
Successful retinoid therapy of Netherton syndrome [in German], 40
-
S. Chavanas, C. Bodemer, A. Rochat, D. Hamel-Teillac, Mohsin Ali, A. Irvine, J. Bonafé, J. Wilkinson, A. Taïeb, Y. Barrandon, J. Harper, Y. Prost, A. Hovnanian (2000)
Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndromeNature Genetics, 25
-
K. Malik, H. He, T. Huynh, G. Tran, K. Mueller, K. Doytcheva, Y. Renert-Yuval, T. Czarnowicki, Shai Magidi, Margaret Chou, Y. Estrada, H. Wen, Xiangyu Peng, Hui Xu, Xiuzhong Zheng, J. Krueger, A. Paller, E. Guttman‐Yassky (2019)
Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signatureThe Journal of Allergy and Clinical Immunology, 143
-
E. Renner, D. Hartl, Stacey Rylaarsdam, Marguerite Young, Linda Monaco-Shawver, G. Kleiner, M. Markert, E. Stiehm, B. Belohradsky, M. Upton, T. Torgerson, Jordan Orange, H. Ochs (2009)
Comèl-Netherton syndrome defined as primary immunodeficiency.The Journal of allergy and clinical immunology, 124 3
-
Hartschuh (1989)
430Hautarzt, 40
-
R. Bissonnette, T. Luger, D. Thaçi, D. Toth, I. Messina, R. You, A. Guana, T. Fox, C. Papavassilis, I. Gilloteau, U. Mrowietz (2017)
Secukinumab sustains good efficacy and favourable safety in moderate‐to‐severe psoriasis after up to 3 years of treatment: results from a double‐blind extension studyBritish Journal of Dermatology, 177
-
Elman (2010)
587Br J Dermatol, 162
- Publisher
- American Medical Association
- Copyright
- Copyright 2020 American Medical Association. All Rights Reserved.
- ISSN
- 2168-6068
- eISSN
- 2168-6084
- DOI
- 10.1001/jamadermatol.2020.1019
- Publisher site
- See Article on Publisher Site
Abstract
This case series evaluates the clinical response to treatment with the interleukin 17 antagonist secukinumab in patients with Netherton syndrome.
Journal
JAMA Dermatology – American Medical Association
Published: Aug 27, 2020